Day 1 - Morning

Group 1A: Metastatic Breast Cancer; ER+; Biomarkers; Liquid Biopsy; Novel Drug Sold Out

Group 1B: Metastatic Breast Cancer; Pharmacokinetics; Drug Dosing; Triple-Negative Breast Cancer Last Few Tickets

Group 1C: Metastatic Breast Cancer; HER2+; Antibody Drug Conjugates; Treatment Resistance; Novel Drug Sold Out

Group 1D: Early-Stage Breast Cancer; ER+; Risk of Recurrence Sold Out

Group 1E: Metastatic Breast Cancer; ER+; Novel Drug Sold Out

Group 1F: Metastatic Breast Cancer; ER+; Liquid Biopsy; Treatment Resistance Sold Out

Group 1G: Breast cancer; Imaging; Artificial Intelligence Sold Out

Group 1H: Breast Cancer; Inflammation; Supportive Care; Supplements; Fatigue Last Few Tickets

Group 1J: Breast Cancer; Young Women; Psychosocial Needs; Quality of Life

Group 1K: Metastatic Breast Cancer; ER+; Biomarkers; Liquid Biopsy; Novel Drug